Levofloxacin
NDC Package 21695-024-10
Package Information
Levofloxacin is used to treat a variety of bacterial infections. Marketed by Rebel Distributors Corp, this product is identified by NDC 21695-024 and is authorized under FDA application ANDA076361.
Identification & Billing
- RxCUI: 199884 - levoFLOXacin 250 MG Oral Tablet
- RxCUI: 199884 - levofloxacin 250 MG Oral Tablet
- RxCUI: 199884 - levofloxacin (as levofloxacin hemihydrate) 250 MG Oral Tablet
- RxCUI: 199885 - levoFLOXacin 500 MG Oral Tablet
- RxCUI: 199885 - levofloxacin 500 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 21695 - Rebel Distributors Corp
- 21695-024 - Levofloxacin
- 21695-024-10 - 10 TABLET, FILM COATED in 1 BOTTLE
- 21695-024 - Levofloxacin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (21695-024). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 21695-024-10 identifies a specific commercial package of 10 tablet, film coated in 1 bottle of Levofloxacin, labeled by Rebel Distributors Corp. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rebel Distributors Corp on June 20, 2011. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Levofloxacin is used to treat a variety of bacterial infections. This medication belongs to a class of drugs known as quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Rebel Distributors Corp product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 21695002410. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.